StoneX Group’s BioRestorative Therapies BRTX Stock Holding History

StoneX Group’s Portfolio BRTX Stock Details BRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.23K	Buy	+13,900	New	+$4.07K	﹤0.01%	1412
2025 Q4	–	Sell	-37,450	Closed	-$54.3K	–	1101
2025 Q3	$54.3K	Sell	37,450 -294	-0.8%	-$455	﹤0.01%	866
2025 Q2	$62.9K	Sell	37,744 -13,448	-26%	-$23.4K	﹤0.01%	815
2025 Q1	$91.1K	Buy	51,192 +1,049	+2%	+$2.01K	0.01%	805
2024 Q4	$71.7K	Buy	+50,143	New	+$77.6K	﹤0.01%	780
2024 Q1	–	Sell	-23,880	Closed	-$41.5K	–	382
2023 Q4	$41.5K	Buy	+23,880	New	+$45.6K	0.02%	309
2022 Q1	–	Sell	-14,954	Closed	-$64.9K	–	556
2021 Q4	$64.9K	Buy	+14,954	New	+$85.4K	0.01%	546

Other funds holding BRTX

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Wealth Alliance Mellville, New York $1.2B AUM 26.51% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

KFGK

Keystone Financial Group (Kentucky) Lexington, Kentucky $1.69B AUM 40.17% 1-Year Est. Return

StoneX Group's BRTX Position: Q2 2026 in Review

StoneX Group opened a new position in BioRestorative Therapies (BRTX) in Q2 2026: 13,900 shares worth $5.23K. The stake represents ﹤0.01% of the portfolio and ranks #1412 among its holdings. This is a return to the name: StoneX Group previously reported a position in BRTX as recently as Q3 2025.

StoneX Group first reported a position in BRTX in Q4 2021 and has held it in 7 quarters since. The position peaked at $91.1K in Q1 2025. 21 funds tracked by Wall St. Rank hold BRTX as of Q2 2026.

StoneX Group held 13,900 shares of BioRestorative Therapies worth $5.23K as of Q2 2026.
BioRestorative Therapies was a new StoneX Group position in Q2 2026.
BioRestorative Therapies made up ﹤0.01% of StoneX Group's portfolio in Q2 2026, its #1412 holding.
StoneX Group first reported a position in BioRestorative Therapies in Q4 2021 and has held it in 7 quarters since.
StoneX Group's BioRestorative Therapies position peaked at $91.1K in Q1 2025.
21 funds tracked by Wall St. Rank held BioRestorative Therapies as of Q2 2026.

Based on StoneX Group's 13F filing for Q2 2026, filed 12 Aug 2026.